Porton Reports Strong Interim Results 2022

The year 2022 is an important milestone for Porton. Despite of the uncertainties of the external environment, we always keep in mind Porton’s mission of "Enabling public’s early access to good medicines" to overcome those challenges and ensure delivery through an agile and stable management system. In the future, we will maintain keen insights and be more proactive in embracing changes so as to empower our business and help good medicines become accessible to the public earlier.